Today’s Market Runner: Could Organovo Holdings Inc See a Reversal After This Very Strong Session?

Today's Market Runner: Could Organovo Holdings Inc See a Reversal After This Very Strong Session?

The stock of Organovo Holdings Inc (NASDAQ:ONVO) is a huge mover today! About 788,849 shares traded hands. Organovo Holdings Inc (NASDAQ:ONVO) has risen 15.45% since April 4, 2016 and is uptrending. It has outperformed by 14.36% the S&P500.
The move comes after 5 months positive chart setup for the $320.09 million company. It was reported on Nov, 4 by We have $6.73 PT which if reached, will make NASDAQ:ONVO worth $425.72 million more.

Analysts await Organovo Holdings Inc (NASDAQ:ONVO) to report earnings on November, 14. They expect $-0.11 EPS, up 8.33% or $0.01 from last year’s $-0.12 per share. After $-0.09 actual EPS reported by Organovo Holdings Inc for the previous quarter, Wall Street now forecasts 22.22% negative EPS growth.

According to Zacks Investment Research, “Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. is based in San Diego, California.”

Insitutional Activity: The institutional sentiment decreased to 1 in Q2 2016. Its down 0.52, from 1.52 in 2016Q1. The ratio dropped, as 3 funds sold all Organovo Holdings Inc shares owned while 35 reduced positions. 11 funds bought stakes while 27 increased positions. They now own 17.18 million shares or 1.14% less from 17.37 million shares in 2016Q1.
Blackrock Investment Mgmt Ltd Liability Corp last reported 337,533 shares in the company. Lpl Fincl Ltd Liability Com holds 0% or 106,520 shares in its portfolio. Cordasco Fin reported 1,100 shares or 0% of all its holdings. Proshare Advsrs Lc has 10,531 shares for 0% of their US portfolio. Kcg Hldgs Inc has 0% invested in the company for 60,929 shares. Geode Cap Management Lc last reported 0% of its portfolio in the stock. Financial Bank Of New York Mellon last reported 0% of its portfolio in the stock. Metropolitan Life Ins Com Ny accumulated 0% or 69,280 shares. Sg Americas Secs Llc accumulated 20,247 shares or 0% of the stock. Pnc Gp accumulated 0% or 6,000 shares. Architects last reported 0% of its portfolio in the stock. Millennium Management Lc accumulated 0% or 30,282 shares. Cypress Capital Ltd Liability (Wy) holds 1,000 shares or 0% of its portfolio. California State Teachers Retirement reported 180,536 shares or 0% of all its holdings. Aqr Capital Limited Co reported 40,200 shares or 0% of all its holdings.

Insider Transactions: Since August 5, 2016, the stock had 0 insider purchases, and 1 sale for $91,000 net activity. 20,000 shares with value of $91,000 were sold by David Eric on Friday, August 5.

More important recent Organovo Holdings Inc (NASDAQ:ONVO) news were published by: which released: “A Dilution Deluge Sends Organovo Holdings, Inc. Lower by 34% in October” on November 02, 2016, also published article titled: “3 Things to Watch in Organovo Holdings, Inc. Q2 Results”, published: “Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation” on October 14, 2016. More interesting news about Organovo Holdings Inc (NASDAQ:ONVO) was released by: and their article: “How Risky Is Organovo Holdings, Inc.?” with publication date: September 12, 2016.

ONVO Company Profile

Organovo Holdings, Inc., incorporated on January 27, 2012, is an early commercial-stage firm focused on developing and commercializing functional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The Firm focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D that mimic native human tissue composition, architecture and function.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment